REFERENCES
- Bowry SK, Kuchinke-Kiehn U, Ronco C. The cardiovascular burden of the dialysis patient: The impact of dialysis technology. Contrib Nephrol. 2005;149:230–239.
- Varela MP, Kimmel PL, Phillips TM, Biocompatibility of hemodialysis membranes: Interrelations between plasma complement and cytokine levels. Blood Purif. 2001;19:370–379.
- MacLeod A, Daly C, Khan I, Comparison of cellulose, modified cellulose and synthetic membranes in the hemodialysis of patients with end-stage renal disease. Cochrane Database Syst Rev. 2001;(3):CD003234.
- Davenport A. Intradialytic complications during hemodialysis. Hemodial Int. 2006;10:162–167.
- Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007;20(5):440–451.
- Boger RH, Zoccali C. ADMA: A novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atheroscler Suppl. 2003;4:23–28.
- Kielstein JT, Boger RH, Bode-Boger SM, Low dialysance of asymmetric dimethylarginine (ADMA)—In vivo and in vitro evidence of significant protein binding. Clin Nephrol. 2004;62:295–300.
- Bergström J, Wehle B. No change in corrected beta 2-microglobulin concentration after cuprophane hemodialysis. Lancet. 1987;1:628–629.
- Krieter DH, Lemke HD, Wanner C. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal. Artif Organs. 2008;32:547–554.
- Wingard RL, Husni L, Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int. 1996;49:551–556..
- Cheung AK. Biocompatibility of hemodialysis membranes. J Am Soc Nephrol. 1990;1:150–161.
- Martin-Malo A, Castillo D, Castro M, Biocompatibility of dialysis membranes: A comparative study. Nephrol Dial Transplant. 1991;6(Suppl. 2):55–58.
- Krane V, Krieter DH, Olschewski M, Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis. 2007;49:267–275.
- Delmez JA, Yan G, Bailey J, Cerebrovascular disease in maintenance hemodialysis patients: Results of the HEMO Study. Am J Kidney Dis. 2006;47:131–138.
- Locatelli F, Martin-Malo A, Hannedouche T, Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20(3):645–654.
- Schiffl H, Lang SM, Stratakis D, Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001;16:1863–1869.
- Kalousova M, Kielstein JT, Hodkova M, No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif. 2006;24:439–444.
- Grooteman MP, Wauters IM, Teerlink T, Plasma dimethylarginine levels in chronic hemodialysis patients are independent of the type of dialyzer applied. Blood Purif. 2007;25:281–289.
- Aoike I. Clinical significance of protein adsorbable membranes–long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant. 2007;22(Suppl 5):v13–v19.
- Yamashita AC, Tomisawa N. Importance of membrane materials for blood purification devices in critical care. Transfus Apher Sci. 2009;40:23–31.
- Yamashita AC, Tomisawa N. Membrane materials for blood purification in critical care. Contrib Nephrol. 2010;166:112–118.
- Opatrny K Jr, Krouzzecky A, Polanska K, Does an alteration of dialyzer design and geometry affect biocompatibility parameters. Hemodial Int. 2006;10:201–208.